G-Quadruplex-Based Nanoscale Coordination Polymers to Modulate Tumor Hypoxia and Achieve Nuclear-Targeted Drug Delivery for Enhanced Photodynamic Therapy
Overview
Authors
Affiliations
Photodynamic therapy (PDT) is a light-triggered therapy used to kill cancer cells by producing reactive oxygen species (ROS). Herein, a new kind of DNA nanostructure based on the coordination between calcium ions (Ca) and AS1411 DNA G quadruplexes to form nanoscale coordination polymers (NCPs) is developed via a simple method. Both chlorine e6 (Ce6), a photosensitizer, and hemin, an iron-containing porphyrin, can be inserted into the G-quadruplex structure in the obtained NCPs. With further polyethylene glycol (PEG) modification, we obtain Ca-AS1411/Ce6/hemin@pHis-PEG (CACH-PEG) NCP nanostructure that enables the intranuclear transport of photosensitizer Ce6 to generate ROS inside cell nuclei that are the most vulnerable to ROS. Meanwhile, the inhibition of antiapoptotic protein B-cell lymphoma 2 (Bcl-2) expression by AS1411 allows for greatly improved PDT-induced cell apoptosis. Furthermore, the catalase-mimicking DNAzyme function of G-quadruplexes and hemin in those NCPs could decompose tumor endogenous HO to in situ generate oxygen so as to further enhance PDT by overcoming the hypoxia-associated resistance. This work develops a simple yet general method with which to fabricate DNA-based NCPs and presents an interesting concept of a nanoscale drug-delivery system that could achieve the intranuclear delivery of photosensitizers, the down-regulation of anti-apoptotic proteins, and the modulation of the unfavorable tumor microenvironment simultaneously for improved cancer therapy.
Light-based technologies in immunotherapy: advances, mechanisms and applications.
Frumento D, talu S Immunotherapy. 2025; 17(2):123-131.
PMID: 40032620 PMC: 11901425. DOI: 10.1080/1750743X.2025.2470111.
Wu Z, Liu Q, Wageh S, Sun Z, Al-Hartomy O, Al-Sehemi A Nanophotonics. 2024; 12(1):81-98.
PMID: 39633642 PMC: 11501689. DOI: 10.1515/nanoph-2022-0520.
Chen M, Xu H, Chang P, Li X, Liu S, Xu L Mater Today Bio. 2024; 29:101318.
PMID: 39534680 PMC: 11554627. DOI: 10.1016/j.mtbio.2024.101318.
Liu X, Wang H, Li Z, Li J, He S, Hu C J Nanobiotechnology. 2024; 22(1):566.
PMID: 39272206 PMC: 11401275. DOI: 10.1186/s12951-024-02839-0.
Engineered photoresponsive biohybrids for tumor therapy.
Wang X, Sun Y, Wangpraseurt D Smart Med. 2024; 2(2):e20220041.
PMID: 39188274 PMC: 11235730. DOI: 10.1002/SMMD.20220041.